« Previous
Next »
Gastroenterology
Volume 138, Issue 3
, Pages 1143-1154.e2
, March 2010
Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: P.R. and P.M. are scientific co-founders of ReOx Ltd, a University spin-out company that seeks to develop HIF Hydroxylase Inhibitors. The remaining authors disclose no conflicts.
Funding Supported by the Emmy Noether-Program of the Deutsche Forschungsgemeinschaft (to MS), by grant IUAP06/30 from the Federal Government Belgium, and by grants FWO G.0265 and FWO G.0387 from the Flanders Research Foundation, Belgium.
PII: S0016-5085(09)01752-1
doi: 10.1053/j.gastro.2009.09.057
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 138, Issue 3
, Pages 1143-1154.e2
, March 2010

